Skip to main content
Erschienen in: Diagnostic Pathology 1/2013

Open Access 01.12.2013 | Research

Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)

verfasst von: Yong sxing Bao, Qian Cao, Ying Yang, Rui Mao, Lei Xiao, Hua Zhang, Hua-rong Zhao, Hao Wen

Erschienen in: Diagnostic Pathology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related deaths, worldwide. It is essential to develop an effective prognostic biomarker and determine the mechanisms underlying HCC invasion and metastasis.

Aims

This study aimed to investigate the expression of Golgi glycoprotein73 (GP73) and Epithelial-mesenchymal transition (EMT) molecules such as E-cadherin and Vimentin in HCC. We also evaluated the prognostic value of GP73 in HCC.

Methods

Immunohistochemistry (IHC) was used to determine the expression of GP73 and EMT molecules in 75 HCC specimens and the corresponding paracarcinomatous liver (PCL) tissues. Spearman’s correlation test was used to analyze the correlation of GP73 and EMT molecules. Clinicopathological features of the HCC patients were also analyzed. Univariate survival analysis was performed by the Kaplan–Meier method and differences among the groups were analyzed by the Log-rank test.

Results

GP73 expression in HCC was higher compared with PCL tissues (χ 2  = 73.60, P < 0.05). EMT molecules were also detected in HCC and PCL tissues. GP73 was negatively correlated with E-cadherin (r = − 0.49, P < 0.05), but positively correlated with Vimentin (r = 0.46, P < 0.05) in HCC. GP73 was correlated with the clinicopathological features including Edmondson grade, vascular invasion and TNM stage (P < 0.05), which was also associated with overall survival (OS) (P < 0.05).

Conclusions

GP73 was negatively with E-cadherin and positively correlated with Vimentin. It might be associated with aggressive behavior of HCC and had influence on patients’ OS. Further research is needed to determine the potential of GP73.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yang Y, Xiao L, Bao Y, et al: Diagnostic value of Golgi-73 and AFP alone or combination in primary hepatocelluar carcinoma. Chin J Lab Med. 2012, 35 (11): 1034-1037. Yang Y, Xiao L, Bao Y, et al: Diagnostic value of Golgi-73 and AFP alone or combination in primary hepatocelluar carcinoma. Chin J Lab Med. 2012, 35 (11): 1034-1037.
2.
Zurück zum Zitat Kladney RD, Bulla GA, Guo L, et al: GP73, a novel Golgi-localized protein upregulated by viral infection. Gene. 2000, 249 (1-2): 53-65. 10.1016/S0378-1119(00)00136-0.CrossRefPubMed Kladney RD, Bulla GA, Guo L, et al: GP73, a novel Golgi-localized protein upregulated by viral infection. Gene. 2000, 249 (1-2): 53-65. 10.1016/S0378-1119(00)00136-0.CrossRefPubMed
3.
Zurück zum Zitat Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol. 2001, 2: 533-543. 10.1016/S1470-2045(01)00486-7.CrossRefPubMed Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol. 2001, 2: 533-543. 10.1016/S1470-2045(01)00486-7.CrossRefPubMed
4.
Zurück zum Zitat Mao Y, Yang H, Xu H, et al: Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010, 59: 1687-1693. 10.1136/gut.2010.214916.CrossRefPubMed Mao Y, Yang H, Xu H, et al: Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010, 59: 1687-1693. 10.1136/gut.2010.214916.CrossRefPubMed
5.
Zurück zum Zitat YangY XL, Bao Y: Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma. Chin J Hepatol. 2012, 20 (12): 920-924. YangY XL, Bao Y: Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma. Chin J Hepatol. 2012, 20 (12): 920-924.
6.
Zurück zum Zitat Mima K, Okabe H, Ishimoto T, et al: CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res. 2012, 72: 3414-3423. 10.1158/0008-5472.CAN-12-0299.CrossRefPubMed Mima K, Okabe H, Ishimoto T, et al: CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res. 2012, 72: 3414-3423. 10.1158/0008-5472.CAN-12-0299.CrossRefPubMed
7.
Zurück zum Zitat Yongli S, Hongyan W, Mingyi Z, et al: Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013, 8: 89-10.1186/1746-1596-8-89.CrossRef Yongli S, Hongyan W, Mingyi Z, et al: Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013, 8: 89-10.1186/1746-1596-8-89.CrossRef
8.
Zurück zum Zitat Kosuke M, Hiromtsu H, et al: Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: clinical significance of transforming growth factor-signaling. Oncol Lett. 2013, 5: 149-154. Kosuke M, Hiromtsu H, et al: Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: clinical significance of transforming growth factor-signaling. Oncol Lett. 2013, 5: 149-154.
9.
Zurück zum Zitat Nehal AR, Nagla SA: The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1 Radwan and Ahmed. Diagn Pathol. 2012, 7: 149-10.1186/1746-1596-7-149.CrossRef Nehal AR, Nagla SA: The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1 Radwan and Ahmed. Diagn Pathol. 2012, 7: 149-10.1186/1746-1596-7-149.CrossRef
10.
Zurück zum Zitat Waly RS, Yangde Z, Yuxiang C: Hepatocellular carcinoma: focus on different aspects of management. Oncology. 2012, 42: 1673- Waly RS, Yangde Z, Yuxiang C: Hepatocellular carcinoma: focus on different aspects of management. Oncology. 2012, 42: 1673-
11.
Zurück zum Zitat Jemal A, Bray F, Center MM, et al: Global cancer statistics. Clin. 2011, 61 (2): 69-90. Jemal A, Bray F, Center MM, et al: Global cancer statistics. Clin. 2011, 61 (2): 69-90.
12.
Zurück zum Zitat Murray G, Duncan M, Arbuckle E, et al: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 1998, 43: 791-797. 10.1136/gut.43.6.791.PubMedCentralCrossRefPubMed Murray G, Duncan M, Arbuckle E, et al: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 1998, 43: 791-797. 10.1136/gut.43.6.791.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Yang J, Mani SA, Donaher JL, et al: Twist, master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004, 117 (5): 927-939.CrossRefPubMed Yang J, Mani SA, Donaher JL, et al: Twist, master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004, 117 (5): 927-939.CrossRefPubMed
14.
Zurück zum Zitat Shen R, Xie F, Shen H, et al: Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells. PLoS One. 2013, 8: 2-CrossRef Shen R, Xie F, Shen H, et al: Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells. PLoS One. 2013, 8: 2-CrossRef
15.
Zurück zum Zitat Shiozaki H, Oka H, Inoue M, et al: E-cadherin mediated adhesion system in cancer cells. Cancer. 1996, 77: 1605-1613.CrossRefPubMed Shiozaki H, Oka H, Inoue M, et al: E-cadherin mediated adhesion system in cancer cells. Cancer. 1996, 77: 1605-1613.CrossRefPubMed
16.
Zurück zum Zitat Bukholm IK, Nesland JM, Karesen R, et al: E-cadherin and a-, b-, and c-catenin protein expression in relation to metastasis in human breast carcinoma. Pathology. 1998, 185: 262-266. 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y. Bukholm IK, Nesland JM, Karesen R, et al: E-cadherin and a-, b-, and c-catenin protein expression in relation to metastasis in human breast carcinoma. Pathology. 1998, 185: 262-266. 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y.
17.
Zurück zum Zitat Van AE, De WO, Correia AS, et al: Defective Ecadherin/catenin complexes in human cancer. Virchows Arch. 2001, 439: 725-751.CrossRef Van AE, De WO, Correia AS, et al: Defective Ecadherin/catenin complexes in human cancer. Virchows Arch. 2001, 439: 725-751.CrossRef
18.
Zurück zum Zitat Kokkinos MA, Wafai R, Wong MK, et al: Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs. 2007, 185: 191-203. 10.1159/000101320.CrossRefPubMed Kokkinos MA, Wafai R, Wong MK, et al: Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs. 2007, 185: 191-203. 10.1159/000101320.CrossRefPubMed
19.
Zurück zum Zitat Qiang H, Lei L, Chen HL, et al: Expression of Smad7 in Cholangiocarcinoma: prognostic Significance and Implications for Tumor Metastasis. Asian Pac J Cancer Prev. 2012, 13: 125-129. Qiang H, Lei L, Chen HL, et al: Expression of Smad7 in Cholangiocarcinoma: prognostic Significance and Implications for Tumor Metastasis. Asian Pac J Cancer Prev. 2012, 13: 125-129.
20.
Zurück zum Zitat Sun Y, Yang H, Mao Y, et al: Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. Hepatology. 2011, 26 (7): 1207-1212. Sun Y, Yang H, Mao Y, et al: Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. Hepatology. 2011, 26 (7): 1207-1212.
21.
22.
Zurück zum Zitat Lorinda MW, Sheri Y, Maria MP: Decreased survival and hepatorenal pathology in mice with C-terminally truncated GP73. Clin Exp Pathol. 2009, 2: 34-47. Lorinda MW, Sheri Y, Maria MP: Decreased survival and hepatorenal pathology in mice with C-terminally truncated GP73. Clin Exp Pathol. 2009, 2: 34-47.
Metadaten
Titel
Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)
verfasst von
Yong sxing Bao
Qian Cao
Ying Yang
Rui Mao
Lei Xiao
Hua Zhang
Hua-rong Zhao
Hao Wen
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Diagnostic Pathology / Ausgabe 1/2013
Elektronische ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-8-197

Weitere Artikel der Ausgabe 1/2013

Diagnostic Pathology 1/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie